Classification of antiviral agents
Pharmacotherapy of chronic viral infection is based on the use of synthetic compounds that suppress pathogen replication. Main drug groups:
- Nucleoside analogues: telbivudine and entecavir.
- Acyclic nucleotide analogues: adefovir (used as a prodrug).
Each substance possesses unique chemical structure characteristics and specific interaction with viral enzymes.
Mechanisms of antiviral action
The drugs aim to suppress hepatitis B virus DNA polymerase:
- Phosphorylation: compounds are activated in the body by enzyme action.
- Competitive inhibition: active metabolites compete with natural substrates for chain incorporation.
- Chain termination: incorporation of the modified component halts further viral DNA synthesis.
Entecavir selectively blocks viral polymerase, while telbivudine additionally causes structural termination of the growing chain.
Pharmacokinetic features and safety profile
Pharmacological properties determine drug prescribing rules:
- Bioavailability: pure adefovir has low rates (about 12%), so it is used as adefovir dipivoxil, which increases absorption up to 60%.
- Toxicity: therapy with adefovir may be accompanied by dose-dependent renal tissue damage (nephrotoxic effect).
- Resistance: entecavir demonstrates an advantage over older agents by minimizing the likelihood of resistant strains emerging.
Limitations for use and regulatory status
The use of antiviral agents is strictly regulated:
- Telbivudine has an age restriction and is prescribed exclusively to patients over 18 years of age with a confirmed diagnosis of chronic infection.
- Adefovir exhibits high activity against strains resistant to lamivudine, but at the time of guideline creation, it was not registered in the Russian Federation.
Briefly: answers to topical questions
Which specific cellular enzymes perform the phosphorylation of telbivudine in hepatocytes?
The phosphorylation of telbivudine into its active form is carried out by cellular kinases. Specific names of the enzymes involved in this process are not specified.
After activation, the resulting triphosphate exerts its mechanism of action:
- Competes with the natural substrate for incorporation into viral DNA.
- Causes chain termination, halting its growth.
- Inhibits hepatitis B virus DNA polymerase.
Against which pathogens, besides hepatitis B virus, does adefovir show activity?
In addition to the hepatitis B virus, adefovir shows activity against many DNA and RNA-containing viruses. Exact names of other pathogens are not provided. Adefovir is also effective against lamivudine-resistant strains of the hepatitis B virus.
Nucleosides inhibit polymerase, adefovir prevents strain resistance, but requires renal monitoring.
Class and exam questions
What is the mechanism of action of telbivudine?
The drug is phosphorylated by cellular kinases, incorporates into viral DNA as a competitor, and causes chain termination while inhibiting viral DNA polymerase.
Why is adefovir used as dipivoxil?
Adefovir itself has low bioavailability upon oral administration (about 12%). The dipivoxil form is successfully hydrolyzed in the blood, increasing this figure to 60%.
What is the main advantage of entecavir?
Entecavir is characterized by a minimal risk of developing drug resistance compared to other nucleoside analogues such as lamivudine.
What are the limitations for prescribing telbivudine?
This thymidine analogue is approved for use only in adult patients over 18 years of age with an established diagnosis of chronic hepatitis B.
What else to study on this topic
- Spectrum of adefovir activity against other DNA and RNA viruses
- Comparative analysis of lamivudine and entecavir resistance
- Metabolic pathways and hydrolysis of adefovir dipivoxil in the systemic circulation
- Cellular kinases and their role in the activation of nucleoside analogues
- Therapy selection criteria in chronic hepatitis B in adults
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Drugs for Hepatitis B Treatment" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Antivirals" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.